Berkshire Hathaway has resumed its share buyback program for the first time since 2024, a significant move for the company under its new leadership.
This decision signals that management, now led by CEO Greg Abel, believes the company's stock is trading below its intrinsic value. The timing is key, as it follows a notable drop in stock price. So, what created this buying opportunity? The primary trigger was the company's fourth-quarter 2025 earnings report, which showed a nearly 30% year-over-year decline in operating income, largely due to a slowdown in the insurance underwriting business. This disappointing result led to a stock price decline of almost 10% from its all-time high in May 2025.
This sequence of events perfectly aligned with Berkshire's updated buyback policy from 2018. The board removed a strict price-to-book value cap, allowing the CEO and Chairman to repurchase shares whenever they conservatively judge the stock to be undervalued. The recent price drop appears to have met this very standard.
Adding another layer of confidence, CEO Greg Abel made a powerful statement by purchasing about $15 million worth of Class A shares with his personal funds just before the company's buyback was announced. This act of 'skin in the game' is crucial for the post-Buffett era, assuring investors that the new leadership's interests are aligned with their own. It effectively counters any uncertainty about the leadership transition and reinforces the message that the stock is a good buy.
With a massive cash pile of over $373 billion and a lack of large-scale acquisition targets, share buybacks represent a logical and efficient way to deploy capital and increase per-share value for remaining shareholders. This move is a clear, confident signal about Berkshire's future from its new leader.
- Share Buyback: A process where a company buys back its own shares from the marketplace, reducing the number of outstanding shares and typically increasing the value of the remaining ones.
- Intrinsic Value: The perceived or calculated 'true' value of an asset, based on fundamental analysis of its underlying financial health, independent of its current market price.
- Skin in the Game: A situation in which high-ranking insiders use their own money to buy stock in the company they are running, demonstrating their belief in the company's prospects.